RPG Life Sciences Limited (RPGLIFE) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE105J01010
Key metrics
- Market Cap
- ₹4,224 Cr
- P/E Ratio
- 34.9
- EPS
- 73.18
- Book Value
- 366.01
- P/B Ratio
- 6.98
- ROE
- 19.03%
- ROCE
- 20.26%
- Debt / Equity
- 0.03
- Net Margin
- 16.41%
- Revenue Growth
- 8.41%
- Profit Growth
- -37.15%
- Dividend Yield
- 0.95%
- 52W High
- ₹3,082.00
- 52W Low
- ₹1,733.00
- Market Cap Band
- small cap
- Face Value
- 8
Ratios computed from the annual results period ending 2026-03-31.
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
- Headquarters
- Mumbai, India
- Employees
- 1,366
- Promoter Holding
- 76.45%
The full RPG Life Sciences Limited analysis
Create a free account to open the complete RPGLIFE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.